Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

Galantamine slowed decline in cognitive function, functional ability, and behavior at 6 months in people with Alzheimer's ...

A new interdisciplinary study at the University of Delaware seeks to study AD by examining changes in the arteries and brain ...

Study finds mosaicism in Down syndrome reduces Alzheimer's risk, providing new insights into genetic influences on cognitive ...

Upon reexamination, the European Medicines Agency has made a U-turn on Eisai and Biogen’s Alzheimer’s disease drug Leqembi. | ...

As technology continues to advance, I’m excited for the future of radiology and the enhanced care it will bring to patients.” ...

Cortechs.ai is the only organization capable of processing both GRE and SWI sequences—settin a new standard for comprehensive and reliable imaging solutions. This capability is essential in today's ...

A thorough evaluation including medical history, physical exams, cognitive tests, and brain imaging, such as MRI or CT scans, ...

However, following a re-examination requested by the company, the CHMP now recommends Leqembi for patients with mild ...

Alzheimer disease (AD) is the sixth leading cause of death in the United States and is projected to affect over 13 million ...

METHODS Proton density and T2 weighted images were obtained on a 1.0 Tesla MRI scanner in patients with dementia with Lewy bodies (consensus criteria; n=27, mean age=75.9 years), Alzheimer’s disease ...

The Mediterranean diet, and in particular the Green Mediterranean diet, may promote better blood sugar management and a ...